APELOA(SZ:000739) Sou Hu Cai Jing·2025-07-29 11:04Core Points - Pro Pharmaceutical Co., Ltd. reported a stock price of 16.72 yuan, an increase of 4.17% as of July 29, 2025 [1] - The company experienced a total revenue of 2.73 billion yuan for Q1 2025, a year-on-year decrease of 14.63% [1] - Net profit attributable to shareholders was 249 million yuan, showing a year-on-year increase of 1.98% [1] Financial Performance - The company's operating revenue for Q1 2025 was 2.73 billion yuan, down 14.63% year-on-year [1] - Net profit for the same period was 249 million yuan, up 1.98% year-on-year [1] - The company's non-recurring net profit was 206 million yuan, a decrease of 14.05% year-on-year [1] - Current ratio stood at 1.505, quick ratio at 1.203, and debt-to-asset ratio at 44.93% [1] Investment and Business Activities - Pro Pharmaceutical has invested in 19 companies and participated in 24 bidding projects [2] - The company holds 125 trademark registrations and 173 patents [2] - Additionally, it possesses 7 administrative licenses [2] Company Background - Pro Pharmaceutical Co., Ltd. was established in 1997 and is located in Jinhua City [1] - The registered capital of the company is approximately 1.17 billion yuan, with paid-in capital of about 363 million yuan [1] - The legal representative of the company is Zhu Fangmeng [1]